Abstract
Comparison of Resected vs. Non-resected PanCO Study Patients with Unresectable Locally Advanced Pancreatic Cancer (uLAPC) Receiving 32P-microparticles and Chemotherapy
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: HPB : the official journal of the International Hepato Pancreato Biliary Association
Paper Title
Journal
Date
